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The extracts of nine selected Nigerian medicinal plants were investigated on Trypanosoma brucei brucei infected mice. The anti-
inflammatory properties of hexane fraction of the most promising U. chamae extract was assessed by acute oedema of the mice paw model while the
modulatory effect of the extract on Delayed-Type Hypersensitivity (DTH) response on in vivo leucocytes mobilization was evaluated. ‘Dose- probing
acute toxicity tests’ established an oral and intraperitoneal LD50 for T. ivorensis stem bark as >1600 < 5000 mg/kg and 100 mg/kg respectively, while
the oral LD50 of Uvaria. chamae was >5000 mg/kg. Extracts of Khaya senegalensis, Harungana madagascariensis, Terminalia ivorensis, Curcuma
longa, Ocimum gratissimum and Alcornea cordifolia showed weak anti-trypanosomal effect and did not exhibit significant clearance in parasitemia at
the test dose administered compared with the positive control (Diminal®). However, the leaf extract of U. chamae and its hexane fraction
demonstrated a significant response (P < 0.01). The fraction at 1000 mg/kg inhibited oedema by 107%. Uvaria. chamae demonstrated both anti-
trypanosomal and anti-inflammatory properties by increasing the survival time of infected mice due to reduction in parasitemia caused by T. brucei
brucei.
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Introduction
Trypanosomosis is a fatal disease of human and domestic animals in tropical Africa and South America spread by the bite of an infected
tsetse fly (Glossina Genus) (Fairlamb, 1982). It has undergone a dramatic and devastating resurgence within the last two decades (Smith et al., 1998),
especially in Sub-Saharan Africa (Welburn et al., 2001). The significance of trypanosomosis on human health, nutrition and economy is enormous,
thereby necessitating continuous research for better ways of eradicating the disease (Atawodi, 2005). Unfortunately, the high cost of chemical drugs,
with the high incidence of their side effects and the emergence of resistance strains has rendered existing chemotherapy inadequate (Atouguia and
Costa, 1999). Therefore, there is need to explore other agents, especially of plant origin for new generations of anti-trypanocidal agents that are more
effective, less toxic, and readily available.
There have been several reports that a vast majority of the population, particularly those living in rural settings, largely depend on herbal
medicines (Gupta, 1994). Natural products (plants and animals) are important sources of new drugs because their derivatives are extremely useful as
lead structures for synthetic modification and optimization of bioactivity (Sülsen et al., 2007). In furtherance of the efforts on sourcing for novel
molecules from natural sources in combating African animal trypanosomosis, previous research on in vivo antitrypanosomal activity is very limited
compared to the in vitro experiments, and in the few in vivo studies found in literature, no complete cure without relapses was recorded for plants such
as Alstonia boonei bark, Annona senegalensis root, Morinda lucida leaves and Picralima nitida (Wosu and Ibe, 1989). Hence, this work was
undertaken to screen selected Nigerian medicinal plants for in vivo antitrypanosomal activity. The studied plants include Khaya senegalensis, A. Juss,
Harungana madagascariensis (Choisy) Poir, Terminalia ivorensis A. Chev., Curcuma longa L., Ocimum gratissimum L., Aloe schweinfurthii Bak.,
Achyranthes aspera Hook F., Uvaria chamae P. Beauv., and leaf and stem of Alcornea cordifolia Schumach & Mill Arg (Table 1). U. chamae being
the most active plant extract was partitioned using solvents of increasing polarity. Since infection models in mice have indicated that African
trypanosomosis trigger anti-inflammatory responses (Namangala et al., 2001), the most active partitioned fraction was therefore evaluated for its anti-
inflammatory response(s) in mice.
Materials and Methods
Plant collection and authentication
The fresh leaves and stem of A. cordifolia Schumach & Mill Arg (Euphorbiaceae), the stem bark of T. ivorensis A. Chev. (Combretaceae)
and U. chamae (R.Br.) Pichon, (Apocynaceae) were collected from Obafemi Awolowo University (OAU) campus, Ile-Ife, Osun State. The plants
were identified and authenticated by Mr. Bernard Omomoh, Herbarium Unit, Department of Botany, OAU Ile-Ife. Voucher specimens IFE
HERBARIUM, 16790, 16398 and 16791 were deposited for A. cordifolia, T. ivorensis and U. chamae respectively. Other plant extracts of Khaya
senegalensis (A. Juss) stem barks, Harungana madagascariensis (Choisy) Poir, the rhizome of Curcuma longa L., the stem of Ocimum gratissimum
L., the leaves of Aloe schweinfurthii Bak., and Achyranthes aspera (Hook F.) leaf, were obtained from the extract store of the Drug Research and
Production Unit (DRPU), OAU, Ile-Ife.
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Table 1: The selected medicinal plants belong to different families and were evaluated for their potential as antitrypanosomosis agent.
Studied plant Family Local name(s) Plant part
used
Ethnomedicinal uses References
Khaya senegalensis Meliaceae Ogonwo (Yoruba,
Nigeria)









stem bark Sap used in the treatment of
scabies and as an anthelmintic
(tapeworms), leaves used as a
remedy for hemorrhages,





Terminalia ivorensis Combretaceae Idigbo (Yoruba,
Nigeria)
stem bark Stem bark is boiled in salted water






Curcuma longa Zingiberaceae Atale pupa (Yoruba)
Gangamau (Hausa)
Rhizome Stomach ache, skin problems
muscular problems and arthritis.
Royal Botanical
Gardens, 2012.
Ocimum gratissimum Lamiaceae Efinrin (Yoruba),
Daidoya (Hausa),
Nchonwu (Ibo).
Stem Treatment of diarrhoea, dysentery
and other gastrointestinal
infections; upper respiratory tract
infections associated with









et al., 2009, El-
said et al., 1969
and Chukwuka et
al., 2011.
Aloe schweinfurthii Aloaceae Gbadu (Nigeria) Leaf Healing agent of burns, skin
ailments and wounds.
Burkill, 1985.
Uvaria chamae Annonaceae Akisan (Yoruba,
Nigeria)
Leaf Leaf sap is used to treat wounds
and sores, leaf infusions is used as
eye wash and leaf decoction is used
as febrifuge.
Ainsilie, 1937
Alcornea cordifolia Euphorbiaceae Ewe ipa (Yoruba) leaf and stem Treatment of toothaches, snake
bites, sore etc. diuretic etc.
Cesario, 1993.
Plant extraction and solvent partitioning
Terminalia ivorensis stem bark was oven dried at 60ºC, while the leaf and stem of A. cordifolia and the leaf of U. chamae were oven dried at
40ºC. Dried plant materials were powdered prior to extraction. T. ivorensis and A. cordifolia (1Kg each) were extracted in 70% ethanol separately,
while U. chamae (1Kg) was extracted in 70% methanol. The samples were allowed to extract in the cold for 72 h with constant shaking using an
electronic laboratory shaker. The filtrates were evaporated in-vacuo at 40ºC to a minimum volume using a rotary evaporator and lyophilized to
complete dryness to give corresponding extract yields. T. ivorensis (14%), U. chamae (7.3 %) and A. cordifolia leaf and stem were 15.4 and 8.1 %
respectively. T. ivorensis (120.04 g) was further partitioned into water and ethyl acetate (1:1v/v) to afford ethyl acetate fraction (21.6 %) yield. U.
chamae (60g) gave the respective partitioned fractions; n-hexane (11.6 %), ethyl acetate (12.6 %) and aqueous (15.5 %), while A. cordifolia extract
(35g) afforded n-hexane and ethyl acetate fractions of 5.4% and 6.7% respectively. Outline of the experimental steps is shown in Fig. 1.
Plant collection and authentication
↓ 
Extraction (70 % MeOH or EtOH)
↓ 
Acute toxicity test (Lorke's method)
↓ 
Culturing of Trypanosoma brucei brucei
↓ 




T. ivorensis (120.04g), A. cordifolia (35 g), U. chamae (60 g)
                                                                ↓                                         ↓                                        ↓ In vivo anti-trypanosomal test of partitioned fractions
EtOAc (21.6 %), n-hex (5.4 %), EtOAc (6.7 %), n-hex (11.6 %), EtOAc (12.6 %), Aq (15.5 %)
                           ↓ 
Anti-Inflammatory tests (n-hexanic fraction of U. chamae)
                                     ↓                              ↓ 
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SAOMP test DHTR test
Figure 1: Outline of the procedures; SAOMP - Systemic Acute Oedema of the mice paw; DHTR - Delayed Type Hypersensitivity Reaction
Test organism
T. brucei brucei strain was obtained from Federal University of Technology, Minna, Niger State, Nigeria. The parasite was maintained in
the laboratory in rats by continuous passage.
Determination of parasitaemia
Parasitemia was monitored in blood obtained from the mice tail, pre-sterilized with ethanol. The number of parasites was determined
microscopically at X400 magnification using the “Rapid Matching” method (Herbert and Lumsden, 1976).
Experimental animals
Healthy mice weighing between 19-25g were purchased from the animal house of Faculty of Pharmacy, OAU, Ile-Ife and kept in well
ventilated cages. They were exposed to 12h light and dark cycles and were fed with pelletized growers mash and water ad libitum. The animals were
allowed a minimum of 7 days acclimatization before use. The animals were treated according to the criteria outlined in the “Guide for the Care and
Use of Laboratory Animals” prepared by the National Academy of Sciences and published by the National Institutes of Health (National Academy
Press, 1996).
Test for toxicity
Acute toxicity of the extract of T. ivorensis (oral and intraperitoneal routes) and U. chamae (oral route) were evaluated using established
method (Lorke, 1983) with 4 groups (n=3) of animals. The control group (I) received 10 % Tween-20, the test groups (II, III, IV) received geometric
doses of 10, 100 and 1000 mg/kg of the extracts respectively. The experimental animals were fasted for 12 h prior to administration of the extracts.
The result obtained from phase 1 test determined the dose selection of 1600, 2900 and 5000 mg/kg for the phase 2 tests. The animals were closely
observed for any signs of toxicity during the first 5 hours, and the number of deaths was recorded at 24, 48 and 72 h.
In - vivo antitrypanosomal assay
For each plant extract, in-vivo antitrypanosomal screening was conducted using 25 mice inoculated with 105 T. brucei brucei parasites in
0.2ml of infected blood via the intraperitoneal route. The parasitaemia count was determined using the method of Herbert and Lumsden (1976). The
animals were divided into 5 groups of 5 animals each. Group 1 mice received 10% Tween-20, groups 2, 3 and 4 mice received different individual
doses of extracts ; (125, 250 and 500) mg/kg ethanolic crude extract and ethyl acetate fraction of T. ivorensis respectively, (3000, 1500 and 750)
mg/kg of C. longa, (2500, 1250 and 625) mg/kg of O. gratissimum, (500, 250 and 125) mg/kg of A. schweinfurthii, (2000, 1000 and 5000) mg/kg of
H. madagascariensis, (1000, 500 and 250) mg/kg of A. cordifolia, (150, 75 and 35) mg/kg of K. senegalensis, (1000, 500 and 250) mg/kg of U.
chamae and (600, 300 and 150) mg/kg of A. aspera. Mice in group 5 served as the positive control and were treated with Diminazene aceturate® at
10 mg/kg. Administered doses of T. ivorensis and U. chamae were based on the experimental LD50 as determined in this study, while the LD50 of
other extracts were used as reported in literature. All treatment commenced when the average parasitaemia was one parasite per field and treatment
continued daily for 6 days. Wet blood film was carried out at every other day to estimate parasitaemia changes and mortality recorded.
Anti-inflammatory tests
Systemic acute Oedema of the mice paw
The systemic acute oedema of the mice paw was investigated using the method of Winter et al. (1962). In this experiment, animals
(n=5/group) received 250, 500 or 1000 mg/kg of U. chamae n- hexane (the most active) fraction orally. Oedema was induced one hour later by
injecting 0.1ml of egg albumin into the sub-planter region of the right hind paw of the mice. The volume of distilled water displaced by the treated
paw was measured at 0, 1, 2, 3, 4 and 5 h after induction of oedema. The negative control group received 10 % Tween-20, while the positive control
group received 100mg/kg indomethacin. Inflammation was assessed as follows:
Vt –V0, where V0 = volume of the treated paw at 0 hr, and Vt = volume at various time.
Delayed type hypersensitivity reaction (DTHR) test
Swiss albino mice (20-25g) of either sex were divided into 5 groups. Each group (n=5) received 250, 500 or 1000 mg/kg of n-hexane
fractions orally. Control animals received either Levamisole (2.5 mg/kg) or 10 % Tween-20. On day zero, one hour after the administration of the
fractions, the mice were sensitised by injecting fresh sheep red blood cells (SRBCs) (0.1 ml of 7.3 × 106 cells/ml) intradermally into the right hind foot
paw. Extract administration was continued daily for 7 days. On day 7, the sensitised animals were challenged by intradermal injection of SRBCs
(0.1ml) into the paw of the left hind foot. The paw size was determined by the volume of distilled water displaced by the paw before and after 24h and
48h. Oedema formation was quantified as the difference in volume of the inflamed paw (Doherty, 1981).
Statistical Analysis
Data were analysed by employing the paired t-test (Snedecor and Cochran, 1967).





The result of acute toxicity of T. ivorensis and U. chamae showed that T. ivorensis (stem bark) extract had low toxicity with LD50 greater
than 1600 mg/kg but lesser than 5000 mg/kg for the oral route, while the LD50 via the intraperitoneal route was 100 mg/kg. U. chamae leaf extract
showed lower toxicity with LD50 of 5000 mg/kg (orally) with no mortality recorded in any test dose up to 5000 mg/kg. The LD50 values of K.
senegalensis (stem bark), H. madagascariensis (bark), C. longa (rhizome), A. cordifolia (leaf), A. aspera (leaf) and O. gratissimum (stem) as
obtained from literature (Table 2) were used for the dose selection for the anti-trypanosomal activity of the plants.
Table 2: Literature LD50 data of K. senegalensis, H. madagascariensis, C. longa, A. cordifolia, A. aspera and O. gratissimum
































Ishaku et al., 2012
Prosper et al., 2012
Sittisomwong et al.,1990
Sittisomwong et al.,1990
Donatien et al., 2010
Barua et al., 2012
Nema et al., 2011
In vivo Antitrypanosomal Experiments
In the in vivo antitrypanosomal experiments, parasites were first detected in all the infected groups on day 2 post-infection (Table 3).
Parasite counts thereafter increased sharply afterwards except for Diminazene aceturate® treated control group with a complete clearance of parasite
on day 3 post inoculation without relapse. In the test groups, extract and fractions of U. chamae showed a complete clearance of the parasite on day 5.
However, relapse was observed on the day 7 post infection.
Anti-trypanosomal activity of the partitioned extracts of U. chamae
Animals treated with n-hexane and ethylacetate fractions of U. chamae had a longer survival period up to day 11 (Table 4). However, the
initial clearance of parasitaemia was followed by a relapse and then death of the animals due to high parasitaemia level.
Table 3: In vivo Antitrypanosomal effects of crude extracts, ethyl acetate fraction of Terminalia ivorensis, Diminazene aceturate® and 10% Tween-20
Mean Trypanosome counts at day 0, 3, 5 and 7Test Sample Dose (mg/kg) Death/
survival 0a 3 5 7
Control (untreated) - 5/0 0 2.13±0.13 15.67±1.43 39.80±0.23
Diminal® 10 5/5 0 0.00±0.00** 0.00±0.00** 0.00±0.00**
500 5/0 0 1.07±0.29* 9.13±0.88 35.07±1.17*
250 5/0 0 1.07±0.22* 6.20±0.77 38.07±0.71
TISE
125 5/0 0 1.13±0.17* 7.87±1.01 37.20±1.82
500 5/0 0 0.73±0.19** 16.07±1.93 31.13±1.64*
250 5/0 0 0.87±0.25* 16.07±1.44 35.00±1.69
TISEt
125 5/0 0 0.47±0.13** 14.53±1.30 33.53±0.81**
1000 5/0 0 1.27±0.036* 0.00±0.00** 12.53±0.85**
500 5/0 0 1.07±0.25 0.00±0.00** 21.93±0.87**
UCL
250 5/0 0 1.27±0.13* 0.00±0.00** 26.60±0.34**
100 5/0 0 3.00±0.67 14.2±0.65 33.87±2.24*
50 5/0 0 0.73±1.19* 12.47±0.77 34.67±1.23*
OGS
25 5/0 0 1.40±0.50 13.13±1.47 32.87±0.40**
500 5/0 0 0.93±0.19** 11.67±0.84 26.60±1.90**
250 5/0 0 1.47±0.20 11.67±1.07 32.20±0.87**
ASL
150 5/0 0 1.00±0.24* 12.40±0.73 36.67±1.77
AAL 500 5/0 0 1.33±0.18* 12.13±0.77 34.60±0.86**
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250 5/0 0 1.37±0.20 10.27±1.38 29.07±1.46**
125 5/0 0 1.33±0.24 9.67±0.46* 27.60±3.70*
1000 5/0 0 1.20±0.20* 8.53±1.31** 31.00±1.29
500 5/0 0 1.60±0.32 10.40±1.61** 30.80±1.91*
ACL
250 5/0 0 1.20±0.27* 10.00±0.97 35.13±2.39
1000 5/0 0 1.20±0.23* 5.87±0.43** 28.33±1.70**
500 5/0 0 1.07±0.13** 8.47±1.30** 34.00±1.28*
ACS
250 5/0 0 1.67±0.11* 12.67±1.12 34.87±1.80
30 5/0 0 1.31±0.22 11.21±1.50 29.51±1.31
15 5/0 0 1.63±0.13 11.22±1.51 31.33±2.10
ACSh
7.5 5/0 0 1.41±0.51 10.81±2.51 33.24±1.04
2000 5/0 0 1.27±0.19* 13.87±1.56 35.67±1.51
100 5/0 0 1.07±0.22** 13.80±0.69 38.00±1.23
HMS
500 5/0 0 1.40±0.13* 14.13±0.89 34.40±1.88
3000 5/0 0 2.53±0.77 18.00±1.38 36.87±0.70*
1500 5/0 0 1.47±0.17* 12.60±0.87 33.47±1.71*
CLR
750 5/0 0 1.47±0.29 11.33±0.89 32.93±1.12**
Legend: Values are Mean ± Standard Error of the Mean. aDay of infection, *Significant as compared to untreated control group (P < 0.05),
**Significant as compared to untreated control group (P < 0.01). TIS - Terminalia ivorensis (stem bark, crude ethanolic extract), TISEt - Terminalia
ivorensis (stem bark, ethylacetate fraction), UCL - Uvaria chamae (leaf extract), OGS - Ocimum gratissimum (stem extract), ASL - Aloe
schweinfurthii (leaf extract), AAL - Achyranthes aspera (leaf extract), ACL - Alcornea cordifolia (leaf extract), ACS - Alcornea cordifolia (stem
extract), HRM - Harungana madagascariensis (stem bark extract), CLR - Curcuma longa (rhizome)
Anti-Inflammatory activities of Uvaria chamae
Anti-Inflammatory activities of U. chamae using systemic Acute Oedema of the mice paw
The inhibitory effect of the hexanic fraction of U. chamae was expressed in all the doses administered (Table 5). Administration of the
fraction profoundly suppressed the development of acute oedema of the mice paw. Generally, it was found to evoke an overall non-dose related effect
with the lowest dose (250 mg/kg) exhibiting the highest inhibition at the 5th hour which was better than that of indomethacin (100 mg/kg). In
comparison with the standard agent, Indomethacin, U. chamae n-hexane fraction at 1000 mg/kg inhibited inflammation all through the experimental
time with the exception of the 5th hour as shown in Table 6.
Delayed Type Hypersensitivity Reaction (DHTR) test
In the Delayed Type Hypersensitivity Reaction (DHTR) anti-inflammatory test (Table 7), extract of U. chamae profoundly inhibited DTHR
induced by SRBCs in a no-dose related manner. The effect of the lowest dose (250 mg/kg) on day 7(a) shows the left paw volume before challenge;
day 7(b) and day 8 show the paw volumes at the 24th and 48th hours after challenge with SRBCs. The paw volume was most reduced by U. chamae at
1000mg/kg on day 8 (1.08 ± 0.08).
Table 4: Antitrypanosomal activities of partitioned fractions of U. chamae
Test fractions / administered
doses
Mean parasitemia counts at day 3, 5, 7, 9 and 11.
3 5 7 9 11
Control (Untreated, 10% tween-
20)
1.07±0.27* 9.33±0.49* 17.93±0.87* 33.00±0.73* ------
n-Hexane (1000 mg/kg) 0.00±0.00* 0.00±0.00** 1.13±0.23** 9.53±0.56** 13.73±8.41
Ethylacetate (1000mg/kg) 0.00±0.00* 0.27±0.19** 6.67±0.89** 22.13±1.93* 25.73±3.15
Aqueous (1000 mg/kg) 0.00±0.00* 9.3±0.19** 9.80±0.75** 25.53±1.53* ------
Diminal® (10 mg/kg) 0.00±0.00** 0.00±0.00** 0.00±0.00** 0.00±0.00** 0.00±0.00
Legend: Values are Mean ± Standard Error of the Mean, *Significant as compared to untreated control group (P < 0.05), **Significant as compared to
untreated control group (P < 0.01), ----- 100% mortality)
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Table 5: Measured paw volume of the mice oedema by n-hexane fraction of U. chamae
Paw Volume (cm) / dose (mg/kg)
Hours 0a 250 500 1000 Indomethacin
0 1.13 ± 0.0250 1.22 ± 0.0200 1.24 ± 0.0245 1.28 ± 0.0250 1.24 ± 0.0245*
1 1.90 ± 0.0408 1.94 ± 0.0510 1.66 ± 0.0678 1.38 ± 0.0250* 1.60 ± 0.0632*
2 1.78 ± 0.0479 1.54 ± 0.0678 1.50 ± 0.0000* 1.23 ± 0.0250* 1.44 ± 0.0600*
3 1.83 ± 0.0854 1.38 ± 0.0583* 1.38 ± 0.0735* 1.40 ± 0.0707* 1.42 ± 0.0663*
4 1.78 ± 0.0250 1.32 ± 0.0735* 1.48 ± 0.0200 1.43 ± 0.0750* 1.54 ± 0.0510*
5 1.78 ± 0.0000 1.29 ± 0.0583* 1.32 ± 0.0583* 1.53 ± 0.0854* 1.48 ± 0.0490*
Legend: Values are Mean ± Standard Error of the Mean, aUntreated control group, *Significant as compared to untreated control group (P < 0.05)
Table 6: Percentage inhibition of the systemic acute oedema of the mice paw by the hexane fraction of U. chamae
Time
(Hours)
Inhibition of systemic acute oedema of the mice paw (%)





































Table 7: Delayed Type Hypersensitivity Reaction (DTHR) test of the hexanic fraction of U. chamae
Paw Volume (cm) / dose (mg/kg)
Days Negative control a 250 500 1000 Levamisole
0 0.88 ± 0.0490 0.96 ± 0.0400 1.03 ± 0.1453 0.90 ± 0.0577 0.95 ± 0.0500
7(a) 1.58 ± 0.0860 1.43 ± 0.0250 1.57 ± 0.0667 1.38 ± 0.0479** 1.38 ± 0.0629
7(b) 1.52 ± 0.0583 1.15 ± 0.0250* 1.40 ± 0.0577 1.22 ± 0.0800 1.20 ± 0.0707
8 1.26 ± 0.0510 1.10 ± 0.0408* 1.23 ± 0.0333 1.08 ± 0.0800 1.18 ± 0.0629
Legend: Values are Mean ± Standard Error of the Mean, 0 = paw volume of the left hind paw of mice before SRBC injection, 7(a) = paw
volume of the right hind paw of mice before SRBC injection, 7(b) = paw volume of the right hind paw of mice after 24h of injection, 8 = paw volume
of the right hind paw of mice after 48h of injection, *= significant as compared to untreated control group (P < 0.05), **= significant as compared to
untreated control group (P < 0.01)
Table 8: Percentage inhibition of oedema in DTHR test of the hexanic fraction
Inhibition of oedema (%)
Days 250 500 1000 Levamisole (2.5) Negative control
0 - - - - -
1 33 23 31 39 0
2 70 42 50 61 0
3 63 47 53 77 0
Legend: % inhibition of the hexanic fraction at different concentrations was significant (P< 0.05) compared with the negative control over the period
of assessment. However, they were not significant compared with the reference drug levamisole.
Discussion
The LD50 values of T. ivorensis stem bark ethanolic extract was found to be 100 mg/kg intraperitoneally, but its oral toxicity was less than
5000 mg/kg. However, the LD50 of U. chamae by the same route of administration was found greater than 5000 mg/kg, and no mortality was observed
in all the test groups. The result indicated the relative safety of both extracts to experimental mice. However, the differences observed in the LD50
values of T. ivorensis via the oral and intraperitoneal routes despite the fact that same extract and doses were administered could be due to different
uptake mechanisms, absorptions, distributions and excretion of the extracts as earlier indicated (Patricia et al., 2005). In previous studies, the in vitro
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antitrypanocidal effect of T. ivorensis ethanolic stem bark extract was evaluated on calf endothelia cells with an LC50 value of 55.71µg/ml (Adewunmi
et al., 2001). In another study, the ethylacetate and ethanolic crude extracts of this plant on Trypanosoma brucei in vitro showed ED50 of 11.11µg/ml
and 12.32µg/ml respectively. However, in this current in vivo study, the previous results were not reproduced. The observed difference in activities
might likely be due to inactivation of the plant's active molecules by metabolic transformation which inhibited the trypanocidal activity under in-vivo
condition as observed with other antitrypanosomal agents (Balber et al., 1985).
The result for the Ocimum gratissimum screening in this work corresponds with earlier reports that no parasitemia clearance was observed
in-vivo (Adamu et al., 2009). Therefore, it does not have trypanocidal effect. Other plants tested in this study did not exhibit significant clearance in
parasitemia at the test doses administered. However, U. chamae extract treated groups demonstrated significant effect with a clearance of parasitemia
at day 5 post inoculation (Table 4). Though a relapse was observed afterwards with some opportunistic manifestations like facial oedema and gradual
loss of condition, the activity of the crude extract necessitated a successive partitioning into n-hexane (11.6%), ethyl acetate (12.6%), and aqueous
(15.5%). The non-polar n-hexanic fraction showed a significant activity with about 50% reduction in parasitemia (13.73 ± 8.41) on day 11 of infection
compared with the ethyl acetate having 25.73 ± 3.15 while the aqueous fractions recorded 100% mortality arising from very high level of infection in
the animals. This result showed that the antitrypanosomal activity exhibited by U. chamae lies in the non-polar hexanic fraction.
This work shows the effect of U. chamae in acute and delayed type anti-inflammatory tests where it inhibited mice paw oedema induced by
egg albumin (Tables 5 - 8). The anti-inflammatory effect of this plant was more pronounced in the acute test where hypersensitivity reaction was
inhibited by 107% at the dose of 1000 mg/Kg (Table 6). This was further supported by the fact that immunosuppression has been linked with
increased susceptibility of trypanosome hosts to secondary infections and has been further studied in this light (Doherty, 1981). This is a relevant
phenomenon, as cattle infected in the field often die of opportunistic infections. Disease-associated suppression also affects host immune response to
trypanosomes.
The presence of alkaloids, saponin, terpenoids, tannin and phenols has been found in the root of the plant (Okwu and Iroabuchi, 2009).
Scientific evidence suggested that these classes of natural constituents exhibit antitrypanosomal activity by virtue of their interference with the redox
balance of the parasites acting either on the respiratory chain or on the cellular defences against oxidative stress (Sepulveda–Boza and Cassels, 1996).
This is because natural products possess structures capable of generating radicals that may cause peroxidative damage to trypanothione reductase that
is very sensitive to alterations in redox balance. Furthermore, a novel monobenzylated monoterpene (Chamanen) had been isolated from the root bark
of U. chamae (William and Charles, 1977). Further studies could disclose the presence of a common moiety for possible interactions with a putative
target receptor and a potential drug-likeness found in the leaf extract.
Conclusion
The n-hexanic fraction of U. chamae exhibited significant in-vivo antitrypanosomal and anti-inflammatory activities. Its anti-inflammatory
responses in the experimental animals could be a probable mechanism for the antitrypanosomal activity demonstrated by the plant. Further purification
of this fraction could indicate a better in-vivo antitrypanosomal activity and this is ongoing in our laboratory.
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